These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879 [Abstract] [Full Text] [Related]
10. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. J Infect Dis; 2006 Mar 01; 193(5):655-63. PubMed ID: 16453260 [Abstract] [Full Text] [Related]
11. [Immune response of rubella vaccine in the populations with different age groups]. Xiong XW, Diao LD, Yan XL. Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug 01; 18(4):227-9. PubMed ID: 9812525 [Abstract] [Full Text] [Related]
13. [Immune status of a school-population sample 5 years after antirubella vaccination]. Quaglio P, Dattoli A, Mantovani G. G Batteriol Virol Immunol; 1982 Aug 01; 75(7-12):233-8. PubMed ID: 7188256 [Abstract] [Full Text] [Related]
16. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector]. Weber HG, Willers H. Fortschr Med; 1982 Jun 24; 100(24):1161-3. PubMed ID: 7106679 [Abstract] [Full Text] [Related]